Overcoming Gastrointestinal Barriers in Colon - Targeted Drug Delivery Systems: A Comprehensive Review of Recent Advances and Emerging Technologies
Future Journal of Pharmaceuticals and Health Sciences · 02.04.2026 · 6 (2) · 1-13
DOI: 10.26452/fjphs.v6i2.551 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Journal of Pharmaceuticals and Health Sciences, online erschienen am 02.04.2026. Verfasst von {"name":"Dr. S. Amudha","email":"amudhakrishnakumar@gmail.com","affiliati und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Colon - targeted drug delivery systems represent a critical therapeutic approach for treating inflammatory bowel diseases, colorectal cancer, and localized infections. However, the complex physiological environment of the gastrointestinal tract presents nume rous challenges that compromise drug delivery efficiency and therapeutic outcomes. This comprehensive review examines the specific challenges that recent colon drug delivery systems aim to overcome in the gastrointestinal tract and evaluates emerging techn ological solutions. A systematic analysis of recent literature (2020 - 2025) was conducted using multiple databases including SciSpace, PubMed, ArXiv, and Google Scholar. Key challenges identified include pH variability (stomach pH 1.5 - 3.5 vs. colon pH 6.5 - 7 .5), heterogeneous transit times (6 - 70 hours colonic residence), dense microbiome interactions (10¹² - 10¹⁴ bacteria/g content), enzymatic degradation, and mucus barrier penetration. Recent innovations include multi - stimuli responsive carriers, microbiome - tr iggered release systems, muco - penetrating nanoparticles, 3D - printed personalized dosage forms, and reactive oxygen species - responsive polymers. Successful colon targeting requires multi - factorial approaches combining pH - independence, microbiome responsiven ess, and mucus penetration capabilities. Emerging technologies show promise for overcoming traditional limitations, though clinical translation remains challenging due to inter - patient variability and regulatory complexities .
Zitieren
APA
Amudha","email":"amudhakrishnakumar@gmail.com","affiliati, N. S., & Sri","email":"amudhakrishnakumar@gmail.com","affiliat, N. D. (2026). Overcoming Gastrointestinal Barriers in Colon - Targeted Drug Delivery Systems: A Comprehensive Review of Recent Advances and Emerging Technologies. Future Journal of Pharmaceuticals and Health Sciences, 6(2), 1-13. https://doi.org/10.26452/fjphs.v6i2.551
Vancouver
Amudha","email":"amudhakrishnakumar@gmail.com","affiliati NS, Sri","email":"amudhakrishnakumar@gmail.com","affiliat ND. Overcoming Gastrointestinal Barriers in Colon - Targeted Drug Delivery Systems: A Comprehensive Review of Recent Advances and Emerging Technologies. Future Journal of Pharmaceuticals and Health Sciences. 2026;6(2):1-13. doi:10.26452/fjphs.v6i2.551
BibTeX
@article{Amudhaemailamudhakrishnakumargmailcomaffiliati2026,
author = {Amudha","email":"amudhakrishnakumar@gmail.com","affiliati, "name":"Dr. S. and Sri","email":"amudhakrishnakumar@gmail.com","affiliat, "name":"G. Dhivya},
title = {Overcoming Gastrointestinal Barriers in Colon - Targeted Drug Delivery Systems: A Comprehensive Review of Recent Advances and Emerging Technologies},
journal = {Future Journal of Pharmaceuticals and Health Sciences},
year = {2026},
volume = {6},
number = {2},
pages = {1--13},
doi = {10.26452/fjphs.v6i2.551}
}
EUVIMED